Welcome to the US Crypto News Morning Briefing—your essential rundown of the most important developments in crypto for the day ahead. Grab a coffee
IPO market’s red-hot year has been cooled by the shutdown and more caution among investors
NEW YORK (AP) — A strong year for initial public offerings on Wall Street has fizzled out due to the government shutdown and a
Should Investors Be Concerned That Netflix Stock Fell After Its 10-For-1 Stock Split?
Netflix fell in lockstep with broader declines in the S&P 500 and Nasdaq Composite. On Nov. 17, a 10-for-1 stock split on Netflix (NFLX
Serious JPMorgan Warning Triggers Urgent Response As Fears Swirl Of 2026 Bitcoin And Crypto Price Crash
Bitcoin and crypto prices have fallen sharply in recent weeks, triggering fears a bitcoin price crash nightmare could be about to come true. Sign
What to Know Before Buying MercadoLibre Stock
Jennifer Saibil, The Motley Fool November 22, 2025 at 5:35 AM Key Points MercadoLibre (NASDAQ: MELI) stock has been a top performer for years,
I Walked Away from a Stable Mid-Career Job — Here’s the Retirement Math Behind that Decision
I can’t think of two words that generate more excitement and fear at the same time than “I quit.” If you’re leaving for a
Child funds compared: ICICI leads with 14%+ 5-year CAGR, SBI trails with 12%; what should you choose
Parents plan for their children’s future with a mix of love, discipline, and long-term financial thinking. Whether through fixed deposits or systematic investment plans
How capital gains tax applies on selling your mutual funds
The amount of tax you owe depends on two main factors Nov 22, 2025 05:22 pm What’s the story When you sell a mutual
Groww eyes wider retail participation; CEO Lalit Keshre says India still early in market investing
Groww CEO Lalit Keshre’s first shareholder letter lays out a long-term, customer-first roadmap driven by product expansion, technology and India’s rising financialisation. Groww ‘);
Big News for Novo Nordisk Stock Investors
Millions of people in the world are overweight, and Novo Nordisk hopes to capture a growing share of this lucrative treatment opportunity. Novo Nordisk